Jubilant Pharmova JUBLPHARMA.NS · INR

Its shares trade on NSE under the ticker JUBLPHARMA.NS. It has been listed since 9 November 1994. In the fiscal year to 31 March 2026, it reported revenue of ₹82.80bn and net income of ₹3.98bn. At that date it held total assets of ₹155.23bn and shareholders' equity of ₹70.93bn.

Jubilant Pharmova Ltd. engages in the provision of basic organic chemicals. The company is headquartered in Noida, Uttar Pradesh. The firm's segments include Pharmaceuticals, Contract Research and Development Services and Proprietary Novel Drugs. The Pharmaceuticals segment, through wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and supply of active pharmaceutical ingredients (APIs), solid dosage formulations, radiopharmaceuticals, allergy therapy products and contract manufacturing of sterile injectables and non-sterile products through six manufacturing facilities in India, United States and Canada and a network of approximately 48 radio pharmacies in the United States. The Contract Research and Development Services segment provides drug discovery and development services as well as clinical data software and service solutions. The Proprietary Novel Drugs segment is a patient-focused biopharmaceutical business working to address unmet medical needs in oncology and autoimmune diseases.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Hari BhartiaNon-Executive Co-Chairman of the Board, since 2023₹1.5m
• Mr. Shyam BhartiaNon-Executive Chairman of the Board, since 2015₹1.5m
• Mr. Arun SharmaChief Financial Officer
• Mr. Naresh KapoorCompliance Officer, Company Secretary
• Mr. Arjun BhartiaJoint Managing Director, Executive Director, since 2017₹75.0m
• Shri. Priyavrat BhartiaManaging Director, Executive Director, since 2017₹75.0m
• Mr. Shirish BelapureNon-Executive Independent Director₹2.4m
• Dr. Harsh MahajanNon-Executive Independent Director₹2.5m
• Mr. Vivek MehraNon-Executive Independent Director₹2.8m
• Ms. Shivpriya NandaNon-Executive Independent Director₹2.9m
• Mr. Sushil RoongtaNon-Executive Independent Director₹2.9m
• Mr. Arun SethNon-Executive Independent Director₹3.1m

Overall

57

Environment

86

Social

67

Governance

20

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.